Literature DB >> 2898790

The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward.

C B Hubner1, M Bird, S Rassnick, C Kornetsky.   

Abstract

3,4-Methylenedioxymethamphetamine (MDMA) is a psychoactive phenylisopropylamine which is structurally similar to both amphetamine-related sympathomimetics and the hallucinogen, mescaline. MDMA produces pleasurable effects which include euphoria, and recent reports continue to demonstrate its widespread recreational use. The aim of the present study was to assess the effects of racemic MDMA on the threshold for rewarding intracranial self-stimulation, an animal model used to assess a drug's abuse liability in man. Rewarding electrical stimulation was delivered via electrodes stereotaxically implanted in the medial forebrain bundle-lateral hypothalamic area of the rat brain. Thresholds were determined by means of a rate-independent psychophysical method. MDMA produced a dose-related lowering of the reward threshold in all four animals tested. Given that increased sensitivity for rewarding brain stimulation, measured as a lowering of the reward threshold, is an animal model of drug-induced euphoria these results suggest a similar mode of action for its reinforcing effects as other abused substances.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898790     DOI: 10.1007/bf00212765

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  Absolute configuration and psychotomimetic activity.

Authors:  G M Anderson; G Braun; U Braun; D E Nichols; A T Shulgin
Journal:  NIDA Res Monogr       Date:  1978

2.  Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria.

Authors:  C Kornetsky
Journal:  NIDA Res Monogr       Date:  1985

3.  Information on "Ecstasy".

Authors:  G Greer; R J Strassman
Journal:  Am J Psychiatry       Date:  1985-11       Impact factor: 18.112

4.  Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse.

Authors:  C Kornetsky; R U Esposito; S McLean; J O Jacobson
Journal:  Arch Gen Psychiatry       Date:  1979-03

5.  Discriminative stimulus properties of MDA analogs.

Authors:  R A Glennon; R Young; J A Rosecrans; G M Anderson
Journal:  Biol Psychiatry       Date:  1982-07       Impact factor: 13.382

6.  Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration.

Authors:  R Esposito; C Kornetsky
Journal:  Science       Date:  1977-01-14       Impact factor: 47.728

7.  Further investigation of the discriminative stimulus properties of MDA.

Authors:  R A Glennon; R Young
Journal:  Pharmacol Biochem Behav       Date:  1984-04       Impact factor: 3.533

8.  3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors.

Authors:  R A Lyon; R A Glennon; M Titeler
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

9.  Discriminative profile of MDMA.

Authors:  M D Schechter
Journal:  Pharmacol Biochem Behav       Date:  1986-06       Impact factor: 3.533

  9 in total
  13 in total

1.  Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine.

Authors:  J Elliott Robinson; Abigail E Agoglia; Eric W Fish; Michael C Krouse; C J Malanga
Journal:  Behav Brain Res       Date:  2012-06-21       Impact factor: 3.332

2.  'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content.

Authors:  Margaret C Wardle; Matthew G Kirkpatrick; Harriet de Wit
Journal:  Soc Cogn Affect Neurosci       Date:  2014-03-27       Impact factor: 3.436

3.  Synthetic cathinones and their rewarding and reinforcing effects in rodents.

Authors:  Lucas R Watterson; M Foster Olive
Journal:  Adv Neurosci (Hindawi)       Date:  2014-06-04

4.  MDMA produces stimulant-like conditioned locomotor activity.

Authors:  L H Gold; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

Authors:  L H Gold; C B Hubner; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.

Authors:  C T Bauer; M L Banks; B E Blough; S S Negus
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

7.  Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats.

Authors:  María Ramos; Beatriz Goñi-Allo; Norberto Aguirre
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

8.  Sex differences in abuse-related neurochemical and behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.

Authors:  M F Lazenka; J A Suyama; C T Bauer; M L Banks; S S Negus
Journal:  Pharmacol Biochem Behav       Date:  2016-08-24       Impact factor: 3.533

9.  4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats.

Authors:  K M Hegadoren; A J Greenshaw; G B Baker; M T Martin-Iverson; B Lodge; S Soin
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

10.  Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.

Authors:  Maria Elena Reveron; Esther Y Maier; Christine L Duvauchelle
Journal:  Behav Brain Res       Date:  2009-11-03       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.